Sandoz Afatinib 40 mg

Sandoz Afatinib 40 mg tablets are a pharmaceutical product used for targeted therapy. This medication is designed to help manage specific types of cancer by inhibiting certain proteins.

Afatinib (afatinib dimaleate) is primarily used in the treatment of non-small cell lung cancer and other types of cancer. It works by targeting specific proteins involved in cancer cell growth. This medication is often prescribed for patients who have certain genetic mutations that make them more responsive to this type of treatment.

Common effects of Afatinib may include skin rash, diarrhea, and nausea. Some users may also experience dry skin, loss of appetite, and fatigue. These effects can vary in severity and may not affect everyone who takes the medication.

Afatinib should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients should be aware of potential side effects and discuss any concerns with their doctor.

Afatinib may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.